Core Viewpoint - The article discusses the potential of low pressure (Hypobaric Pressure, HP) as a natural Senolytic therapy to selectively induce the death of senescent cells, which are linked to aging and age-related diseases, thereby providing a new non-pharmaceutical intervention strategy for anti-aging [2][11]. Group 1: Research Findings - A study published in Nature Biomedical Engineering reveals that intermittent hypobaric pressure can induce selective senescent cell death and alleviate age-related osteoporosis [3]. - The research indicates that low pressure environments can activate the mechanosensitive ion channel TMEM59, leading to the specific clearance of senescent cells and significant lifespan extension [3][11]. - The study found that low pressure treatment at -375 mmHg induces lysosome-dependent cell death (LDCD) in mesenchymal stem cells, which is mediated by calcium ion influx and activation of calpain 2 [7][9]. Group 2: Mechanism of Action - Low pressure activates the TMEM59 receptor, which triggers calcium ion influx, resulting in increased lysosomal membrane permeability and subsequent LDCD, effectively clearing senescent cells while protecting normal cells [9][11]. - The research confirms that intermittent low pressure treatment can significantly extend the lifespan of aged mice and improve their osteoporosis phenotype [10][15]. Group 3: Implications for Anti-Aging - The findings suggest that low pressure could serve as a "smart" method to identify and eliminate senescent cells, offering a precise approach to anti-aging therapies [9][11]. - This research not only provides insights into modern scientific interpretations of traditional Chinese medicine but also opens new avenues for non-drug interventions in the field of anti-aging [3][11].